A new study finds that antibodies produced in the nose decline nine months after COVID-19 infection, while antibodies found in the blood last at least a year.
Dec 19, 2022
0
97
A drug in development for obstructive sleep apnea (OSA) has shown promising results, after researchers from Flinders University tested the treatment in people for the first time.
Dec 8, 2022
0
44
We have vaccines to boost our immune response to SARS-CoV-2, the virus that causes COVID. We have medicines you can take at home (and in hospital) to treat COVID. Now researchers are trialing something new.
Nov 28, 2022
0
20
The U.S. Food and Drug Administration appears poised to approve certain naloxone products for over-the-counter use, a move that would help fight the nation's opioid epidemic.
Nov 16, 2022
0
39
Hay fever (also known as allergic rhinitis) is a catch-all term that covers a group of ailments that cause sneezing, a runny nose, and itchy and red eyes.
Nov 9, 2022
0
5
As the pandemic continues, many countries are rolling out COVID booster vaccines. In the U.K., the autumn booster campaign is offering a fourth dose to those at higher risk from a COVID infection, including people with certain ...
Nov 8, 2022
0
6
Flu season usually peaks in winter; however, the best time to prevent infection is before the virus appears in a community.
Oct 20, 2022
0
2
On January 13, 2020, a paper touting the creation of a possible therapy that could be used to fight all known strains of the flu was published online.
Oct 20, 2022
0
163
It's flu season, during which approximately 30 million Americans will get the flu, according to the Centers for Disease Control and Prevention. Fortunately, most of those cases don't require medical attention and can be treated ...
Oct 13, 2022
0
20
An experimental approach to enhancing a standard cat allergy treatment made it more effective and faster acting, and the benefits persisted for a year after treatment ended, a study supported by the National Institutes of ...
Oct 11, 2022
0
38
